XOMA Royalty (XOMA) EBT Growth (1y) (2012 - 2026)
XOMA Royalty (XOMA) EBT Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
-88.68% |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
13.34% |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
-51.60% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
-313.33% |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
-79.57% |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
-230.18% |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
71.54% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
88.68% |
| Date | Value |
|---|
| Mar 31, 2026 |
88.68% |
| Dec 31, 2025 |
-364.44% |
| Sep 30, 2025 |
181.77% |
| Jun 30, 2025 |
110.14% |
| Mar 31, 2025 |
122.43% |
| Dec 31, 2024 |
149.09% |
| Sep 30, 2024 |
-197.96% |
| Jun 30, 2024 |
-126.31% |
| Mar 31, 2024 |
-3.79% |
| Dec 31, 2023 |
-221.00% |
| Sep 30, 2023 |
-32.37% |
| Jun 30, 2023 |
-24.96% |
| Mar 31, 2023 |
-392.49% |
| Dec 31, 2022 |
-120.74% |
| Sep 30, 2022 |
1.44% |
| Jun 30, 2022 |
-113.10% |
| Mar 31, 2022 |
71.99% |
| Dec 31, 2021 |
31.97% |
| Sep 30, 2021 |
-311.88% |
| Jun 30, 2021 |
36.68% |
